Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Postoperative Cardiac Complications and Long-Term Mortality After Emergency Lower Limb Orthopedic Surgery

被引:32
作者
Chong, Carol P. [1 ,3 ,4 ,5 ]
Ryan, Julie E. [2 ]
van Gaal, William J. [3 ,5 ]
Lam, Que T. [2 ]
Sinnappu, Rabindra N. [1 ]
Burrell, Louise M. [5 ,6 ]
Saviae, Judy [4 ,5 ]
Lim, Wen Kwang [1 ,4 ,5 ]
机构
[1] Northern Hosp, Dept Aged Care, Epping, NSW, Australia
[2] Northern Hosp, Dept Biochem Austin Pathol, Epping, NSW, Australia
[3] Northern Hosp, Dept Cardiol, Epping, NSW, Australia
[4] Univ Melbourne, No Clin Res Ctr, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Med Austin & No Hlth, Melbourne, Vic, Australia
[6] Dept Cardiol, Heidelberg, Vic, Australia
关键词
NONCARDIAC SURGERY; EVENTS; RISK; MARKER; ASSOCIATION; UTILITY;
D O I
10.1016/j.amjcard.2010.05.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
After emergency orthopedic geriatric surgery, cardiac complications are an important cause of morbidity and mortality. The utility of N-terminal pro brain natriuretic peptide (NT-pro-BNP) for the prediction of cardiac complications and mortality was evaluated. NT-pro-BNP was tested pre- and postoperatively in 89 patients >60 years of age. They were followed for 2 years for cardiac complications (defined as acute myocardial infarction, congestive cardiac failure, atrial fibrillation or major arrhythmia) or death. Receiver operating characteristic curves were constructed to determine the optimal discriminatory level for cardiac events and death using NT-pro-BNP. Twenty-three patients (25.8%) sustained an in-hospital postoperative cardiac complication. Total all-cause mortality was 3 of 89 (3.4%) in hospital, 21 of 89(23.6%) at 1 year, and 27 of 89(30.3%) at 2 years. Median preoperative and postoperative NT-pro-BNP levels were higher in patients who had an in-hospital cardiac event compared to those without (387 vs 1,969 pg/ml, p < 0.001; and 676 vs 7,052 pg/ml, p < 0.001 respectively). The optimal discriminatory level for preoperative NT-pro-BNP was 842 pg/ml and that for postoperative NT-pro-BNP was 1,401 pg/ml for the prediction of in-hospital cardiac events and 1- and 2-year mortality. Preoperative NT-pro-BNP >= 842 pg/ml (odds ratio 11.6, 95% confidence interval 2.1 to 65.0, p = 0.005) was an independent predictor of in-hospital cardiac complications using multivariate analysis and pre- and postoperative NT-pro-BNP levels were independent predictors of 2-year cardiovascular events. Patients who had preoperative NT-pro-BNP was 842 pg/ml or postoperative NT-pro-BNP >= 1,401 pg/ml had significantly worse survival using log-rank testing (p < 0.001) and these variables independently predicted 2-year mortality. In conclusion, increase pre- and postoperative NT-pro-BNP levels are independent predictors of in-hospital cardiac events and 1- and 2-year mortality in older patients undergoing emergency orthopedic surgery. Crown Copyright (C) 2010 Published by Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106:865-872)
引用
收藏
页码:865 / 872
页数:8
相关论文
共 21 条
  • [1] Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome
    Ausset, S.
    Auroy, Y.
    Lambert, E.
    Vest, P.
    Plotton, C.
    Rigal, S.
    Lenoir, B.
    Benhamou, D.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (02) : 158 - 164
  • [2] Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients
    Chong, Carol P.
    Lam, Que T.
    Ryan, Julie E.
    Sinnappu, Rabindra N.
    Lim, Wen Kwang
    [J]. AGE AND AGEING, 2009, 38 (02) : 168 - 174
  • [3] Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery
    Cuthbertson, B. H.
    Almiri, A. R.
    Croal, B. L.
    Rajagopalan, S.
    Alozairi, O.
    Brittenden, J.
    Hillis, G. S.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2007, 99 (02) : 170 - 176
  • [4] Postoperative myocardial damages are a key issue in patients' outcome after hip fracture
    Daban, J. L.
    De Saint Maurice, G. Pelee
    Batjom, E.
    Falzone, E.
    Ausset, S.
    [J]. AGE AND AGEING, 2009, 38 (04) : 488 - 489
  • [5] Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients
    Dernellis, J.
    Panaretou, M.
    [J]. HEART, 2006, 92 (11) : 1645 - 1650
  • [6] Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk
    Devereaux, PJ
    Goldman, L
    Cook, DJ
    Gilbert, K
    Leslie, K
    Guyatt, GH
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (06) : 627 - 634
  • [7] Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery
    Feringa, Harm H. H.
    Schouten, Olaf
    Dunkelgrun, Martin
    Bax, Jeroen J.
    Boersma, Eric
    Elhendy, Abdou
    de Jonge, Robert
    Karagiannis, Stefanos E.
    Vidakovic, Radosav
    Poldermans, Don
    [J]. HEART, 2007, 93 (02) : 226 - 231
  • [8] Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass
    Feringa, Harm H. H.
    Bax, Jeroen J.
    Elhendy, Abdou
    de Jonge, Robert
    Lindemans, Jan
    Schouten, Olaf
    van den Meiracker, Anton H.
    Boersma, Eric
    Schinkel, Arend F. L.
    Kertai, Miklos D.
    van Sambeek, Marc R. H. M.
    Poldermans, Don
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (01) : 111 - 115
  • [9] Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery
    Goei, Dustin
    Schouten, Olaf
    Boersma, Eric
    Welten, Gijs M. J. M.
    Dunkelgrun, Martin
    Lindemans, Jan
    van Gestel, Yvette R. B. M.
    Hoeks, Sanne E.
    Bax, Jeroen J.
    Poldermans, Don
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (01) : 122 - 126
  • [10] Hammerer-Lercher A, 2001, Clin Lab, V47, P265